CG
MDLN

Carlyle Group’s Medline Inc MDLN Stock Holding History

Carlyle Group’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.38B Hold
187,083,713
– – 73.78% 1
2026
Q1 		$8.33B Sell
187,083,713
-28,219,323
-13% -$1.25B 78.4% 1
2025
Q4 		$9.04B Buy
+215,303,036
New +$9.09B 66.65% 1

Other funds holding MDLN

HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Carlyle Group's MDLN Position: Q2 2026 in Review

Carlyle Group held its Medline Inc (MDLN) position steady in Q2 2026 at 187,083,713 shares worth $7.38B. The position accounts for 73.78% of the portfolio, ranked #1.

Carlyle Group first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. The position peaked at $9.04B in Q4 2025. 406 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Carlyle Group held 187,083,713 shares of Medline Inc worth $7.38B as of Q2 2026.
  • Carlyle Group left its Medline Inc share count unchanged in Q2 2026.
  • Medline Inc made up 73.78% of Carlyle Group's portfolio in Q2 2026, its #1 holding.
  • Carlyle Group first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • Carlyle Group's Medline Inc position peaked at $9.04B in Q4 2025.
  • 406 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Carlyle Group's 13F filing for Q2 2026, filed 7 Aug 2026.